Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lilly describes use of dihydrobenzo[b]indenothiophenes for estrogen-related pathologies

Dec. 1, 1998

Australian team demonstrates safety of diabetes vaccine in patients

Nov. 30, 1998

Fujisawa discovers V-ATPase inhibitor with potential for treating osteoporosis

Nov. 30, 1998

Banyu reports success in the search for new ACAT inhibitors

Nov. 30, 1998

TAK-778: candidate for development in the treatment of osteoporosis

Nov. 30, 1998

New market introductions for raloxifene

Nov. 30, 1998

Somatostatin sst2 agonists synthesized at Merck & Co.

Nov. 27, 1998

Cerus makes steady progress with platelet pathogen inactivation system

Nov. 27, 1998

NE reuptake inhibitor from Lilly shows antiobesity activity in animal models

Nov. 27, 1998

Agents for diabetes and related disorders developed by Dr. Reddy's team

Nov. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...